GWM
AMED

Geneos Wealth Management’s Amedisys AMED Stock Holding History

Geneos Wealth Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-56
Closed -$5.51K – 2502
2025
Q2 		$5.51K Sell
56
-96
-63% -$9.08K ﹤0.01% 2546
2025
Q1 		$14.1K Buy
152
+110
+262% +$10.1K ﹤0.01% 2464
2024
Q4 		$3.81K Sell
42
-7
-14% -$643 ﹤0.01% 2420
2024
Q3 		$4.73K Buy
+49
New +$4.78K ﹤0.01% 2085
2022
Q3 		– Sell
-179
Closed -$19K – 2019
2022
Q2 		$19K Hold
179
– – ﹤0.01% 1693
2022
Q1 		$30K Sell
179
-95
-35% -$14.2K ﹤0.01% 1599
2021
Q4 		$44K Sell
274
-1,806
-87% -$290K ﹤0.01% 1530
2021
Q3 		$300K Hold
2,080
– – 0.01% 713
2021
Q2 		$550K Sell
2,080
-217
-9% -$56.9K 0.02% 543
2021
Q1 		$619K Sell
2,297
-35
-2% -$9.87K 0.02% 579
2020
Q4 		$588K Buy
2,332
+83
+4% +$21.3K 0.02% 493
2020
Q3 		$522K Buy
2,249
+472
+27% +$107K 0.03% 418
2020
Q2 		$365K Sell
1,777
-419
-19% -$78.1K 0.02% 488
2020
Q1 		$364K Buy
2,196
+419
+24% +$74.5K 0.02% 439
2019
Q4 		$294K Hold
1,777
– – 0.02% 562
2019
Q3 		$229K Sell
1,777
-18
-1% -$2.34K 0.01% 607
2019
Q2 		$217K Sell
1,795
-19
-1% -$2.25K 0.01% 642
2019
Q1 		$223K Hold
1,814
– – 0.01% 609
2018
Q4 		$208K Hold
1,814
– – 0.02% 587
2018
Q3 		$226K Hold
1,814
– – 0.02% 596
2018
Q2 		$155K Hold
1,814
– – 0.01% 631
2018
Q1 		$109K Hold
1,814
– – 0.01% 726
2017
Q4 		$95K Hold
1,814
– – 0.01% 760
2017
Q3 		$101K Sell
1,814
-30
-2% -$1.59K 0.01% 694
2017
Q2 		$115K Buy
1,844
+67
+4% +$3.9K 0.01% 642
2017
Q1 		$90K Hold
1,777
– – 0.01% 687
2016
Q4 		$75K Hold
1,777
– – 0.01% 690
2016
Q3 		$84K Hold
1,777
– – 0.01% 641
2016
Q2 		$90K Hold
1,777
– – 0.01% 622
2016
Q1 		$86K Buy
+1,777
New +$68.6K 0.01% 632

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Geneos Wealth Management's AMED Position: Q3 2025 in Review

Geneos Wealth Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 56 shares — an estimated $5.51K sold.

Geneos Wealth Management first reported a position in AMED in Q1 2016 and held it in 30 quarters. The position peaked at $619K in Q1 2021. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Geneos Wealth Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 56 Amedisys shares in Q3 2025, an estimated $5.51K.
  • Geneos Wealth Management first reported a position in Amedisys in Q1 2016 and held it in 30 quarters.
  • Geneos Wealth Management's Amedisys position peaked at $619K in Q1 2021.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.